Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

SHE:301089 Statistics

Total Valuation

SHE:301089 has a market cap or net worth of CNY 3.71 billion. The enterprise value is 3.46 billion.

Market Cap	3.71B
Enterprise Value	3.46B

Important Dates

The next estimated earnings date is Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:301089 has 126.54 million shares outstanding. The number of shares has decreased by -9.24% in one year.

Current Share Class	126.54M
Shares Outstanding	126.54M
Shares Change (YoY)	-9.24%
Shares Change (QoQ)	-18.59%
Owned by Insiders (%)	54.77%
Owned by Institutions (%)	1.10%
Float	57.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.10
PB Ratio	2.44
P/TBV Ratio	2.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-72.98
EV / Sales	9.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-38.22

Financial Position

The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.00.

Current Ratio	4.69
Quick Ratio	2.98
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-382.51

Financial Efficiency

Return on equity (ROE) is -3.07% and return on invested capital (ROIC) is -5.25%.

Return on Equity (ROE)	-3.07%
Return on Assets (ROA)	-2.41%
Return on Invested Capital (ROIC)	-5.25%
Return on Capital Employed (ROCE)	-4.25%
Weighted Average Cost of Capital (WACC)	-0.41%
Revenue Per Employee	236,940
Profits Per Employee	-30,556
Employee Count	1,551
Asset Turnover	0.21
Inventory Turnover	1.47

Taxes

Income Tax	-5.95M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.85% in the last 52 weeks. The beta is -0.85, so SHE:301089's price volatility has been lower than the market average.

Beta (5Y)	-0.85
52-Week Price Change	+14.85%
50-Day Moving Average	30.43
200-Day Moving Average	31.89
Relative Strength Index (RSI)	44.57
Average Volume (20 Days)	4,930,493

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301089 had revenue of CNY 367.49 million and -47.39 million in losses. Loss per share was -0.40.

Revenue	367.49M
Gross Profit	108.23M
Operating Income	-66.35M
Pretax Income	-53.34M
Net Income	-47.39M
EBITDA	-18.44M
EBIT	-66.35M
Loss Per Share	-0.40

Balance Sheet

The company has 254.83 million in cash and 3.22 million in debt, with a net cash position of 251.61 million or 1.99 per share.

Cash & Cash Equivalents	254.83M
Total Debt	3.22M
Net Cash	251.61M
Net Cash Per Share	1.99
Equity (Book Value)	1.52B
Book Value Per Share	12.03
Working Capital	478.55M

Cash Flow

In the last 12 months, operating cash flow was -29.25 million and capital expenditures -61.25 million, giving a free cash flow of -90.50 million.

Operating Cash Flow	-29.25M
Capital Expenditures	-61.25M
Free Cash Flow	-90.50M
FCF Per Share	-0.72

Margins

Gross margin is 29.45%, with operating and profit margins of -18.05% and -12.90%.

Gross Margin	29.45%
Operating Margin	-18.05%
Pretax Margin	-14.52%
Profit Margin	-12.90%
EBITDA Margin	-5.02%
EBIT Margin	-18.05%
FCF Margin	n/a

Dividends & Yields

SHE:301089 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	9.24%
Shareholder Yield	9.24%
Earnings Yield	-1.28%
FCF Yield	-2.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHE:301089 has an Altman Z-Score of 15.33 and a Piotroski F-Score of 2.

Altman Z-Score	15.33
Piotroski F-Score	2